Volume 6 Issue 6
Nov.  2015
Turn off MathJax
Article Contents
Xia Wei, Yan Jie, Mao Wenjun, et al. Curative effect and prognosis analysis of lung transplantation for patients over 65 years old with end-stage lung diseases[J]. ORGAN TRANSPLANTATION, 2015, 6(6): 382-387. doi: 10.3969/j.issn.1674-7445.2015.06.007
Citation: Xia Wei, Yan Jie, Mao Wenjun, et al. Curative effect and prognosis analysis of lung transplantation for patients over 65 years old with end-stage lung diseases[J]. ORGAN TRANSPLANTATION, 2015, 6(6): 382-387. doi: 10.3969/j.issn.1674-7445.2015.06.007

Curative effect and prognosis analysis of lung transplantation for patients over 65 years old with end-stage lung diseases

doi: 10.3969/j.issn.1674-7445.2015.06.007
More Information
  • Corresponding author: Mao Wenjun, Email: maowenjun1@126.com
  • Received Date: 2015-08-20
    Available Online: 2021-01-19
  • Publish Date: 2015-11-15
  •   Objective  To investigate the curative effect and prognosis of lung transplantation for patients over 65 years old with end-stage lung diseases.  Methods  Clinical data of 24 elderly patients (≥65 years old) undergoing lung transplantation in Affiliated Wuxi People's Hospital of Nanjing Medical University from September 2002 to December 2011 were retrospectively analyzed. The survival conditions of elderly patients undergoing lung transplantation were studied and the survival conditions of unilateral lung transplantation and bilateral lung transplantation were compared. The complications after lung transplantation were observed and the death causes of patients died during the follow-up period was analyzed.  Results  All patients completed the lung transplantation successfully. The 1, 3, 5 and 7-year cumulative survival rate of the 24 patients were respectively 75.0%, 62.5%, 33.3% and 12.5%, and those of patients undergoing unilateral lung transplantation were respectively 68.8%, 50.0%, 31.3% and 12.5% and those of the patients undergoing bilateral lung transplantation were respectively 87.5%, 87.5%, 37.5% and 12.5%. The median survival time of the patients undergoing unilateral lung transplantation and bilateral lung transplantation was respectively 35 months and 51 months, and there was no significant difference (P>0.05). The primary postoperative complication was infection with the incidence of 46% (11/24). Seventeen patients died during the long-term follow-up. Among them, 9 died of severe infection, 1 died of primary graft dysfunction (PGD), 1 died of acute rejection (AR), 4 died of bronchiolitis obliterans syndrome (BOS), 1 died of heart failure and 1 died of tumor.  Conclusions  Unilateral lung transplantation and bilateral lung transplantation are both effective methods to treat elderly patients with end-stage lung diseases. Infection is the primary postoperative complication and the cause of death of elderly patients.

     

  • loading
  • [1]
    李慧星, 毛文君, 陈静瑜, 等.肺叶切除术治疗双肺移植术后肺不张疗效分析[J].器官移植, 2014, 5(1):24-27, 31. http://www.organtranspl.com/browse/detail/qkid/84/id/237.html

    Li HX, Mao WJ, Chen JY, et al. Analysis of curative effect of pulmonary lobectomy on atelectasis after lung transplantation[J]. Organ Transplant, 2014, 5(1):24-27, 31. http://www.organtranspl.com/browse/detail/qkid/84/id/237.html
    [2]
    徐海英, 毛文君, 陈静瑜, 等.公民逝世后器官捐献供肺的评估及获取经验19例报告[J].中华器官移植杂志, 2014, 35(7):396-400. doi: 10.3760/cma.j.issn.0254-1785.2014.07.004

    Xu HY, Mao WJ, Chen JY, et al. Experience of donation after citizens death for lung transplant: report of 19 cases[J]. Chin J Organ Transplant, 2014, 35(7):396-400. doi: 10.3760/cma.j.issn.0254-1785.2014.07.004
    [3]
    Yusen RD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report:2014; focus theme: retransplantation[J]. J Heart Lung Transplant, 2014, 33(10):1009-1024. doi: 10.1016/j.healun.2014.08.004
    [4]
    Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report:2013;focus theme: age[J]. J Heart Lung Transplant, 2013, 32(10):965-978. doi: 10.1016/j.healun.2013.08.007
    [5]
    Fildes JE, Archer LD, Blaikley J, et al. Clinical outcome of patients transplanted with marginal donor lungs via ex vivo lung perfusion compared to standard lung transplantation[J]. Transplantation, 2015, 99(5):1078-1083. doi: 10.1097/TP.0000000000000462
    [6]
    Kreider M, Kotloff RM. Selection of candidates for lung transplantation[J]. Proc Am Thorac Soc, 2009, 6(1):20-27. doi: 10.1513/pats.200808-097GO
    [7]
    Mahidhara R, Bastani S, Ross DJ, et al. Lung transplantation in older patients?[J]. J Thorac Cardiovasc Surg, 2008, 135(2):412-420. doi: 10.1016/j.jtcvs.2007.09.030
    [8]
    Machuca TN, Camargo SM, Schio SM, et al. Lung transplantation for patients older than 65 years: is it a feasible option?[J]. Transplant Proc, 2011, 43(1):233-235. doi: 10.1016/j.transproceed.2010.12.010
    [9]
    Weiss ES, Merlo CA, Shah AS. Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data[J]. J Am Coll Surg, 2009, 208(3):400-409. doi: 10.1016/j.jamcollsurg.2008.12.010
    [10]
    Machuzak M, Santacruz JF, Gildea T, et al. Airway complications after lung transplantation[J]. Thorac Surg Clin, 2015, 25(1):55-75. doi: 10.1016/j.thorsurg.2014.09.008
    [11]
    Gutierrez C, Al-Faifi S, Chaparro C, et al. The effect of recipient's age on lung transplant outcome[J]. Am J Transplant, 2007, 7(5):1271-1277. doi: 10.1111/ajt.2007.7.issue-5
    [12]
    Riera J, Caralt B, López I, et al. Ventilator-associated respiratory infection following lung transplantation[J]. Eur Respir J, 2015, 45(3):726-737. doi: 10.1183/09031936.00095214
    [13]
    Dorgan DJ, Hadjiliadis D. Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities[J]. Expert Rev Respir Med, 2014, 8(3):315-326. doi: 10.1586/17476348.2014.899906
    [14]
    张晓峰, 陈国千, 吴国荣, 等.肺移植受者血清可溶性白细胞介素-2受体检测的临床应用[J].实用医学杂志, 2012, 28(20):3463-3464. http://www.cqvip.com/qk/93362x/201220/43685189.html

    Zhang XF, Chen GQ, Wu GR, et al. Clinical application of detection of serum soluble interleukin-2 receptor of lung transplant recipients[J]. J Pract Med, 2012, 28(20):3463-3464. http://www.cqvip.com/qk/93362x/201220/43685189.html
    [15]
    Patel N, Snyder LD, Finlen-Copeland A, et al. Is prevention the best treatment? CMV after lung transplantation[J]. Am J Transplant, 2012, 12(3):539-544. doi: 10.1111/j.1600-6143.2011.03837.x
    [16]
    Hayes D Jr, Weiland A, Kirkby S, et al. Gram-negative infection and bronchiectasis in lung transplant recipients with bronchiolitis obliterans syndrome[J]. Thorac Cardiovasc Surg, 2013, 61(3):240-245. http://cn.bing.com/academic/profile?id=2023779572&encoded=0&v=paper_preview&mkt=zh-cn
    [17]
    Hayes D Jr, Mansour HM, Kirkby S, et al. Rapid acute onset of bronchiolitis obliterans syndrome in a lung transplant recipient after respiratory syncytial virus infection[J]. Transpl Infect Dis, 2012, 14(5):548-550. doi: 10.1111/tid.2012.14.issue-5
    [18]
    Ghassemieh B, Ahya VN, Baz MA, et al. Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation[J]. J Heart Lung Transplant, 2013, 32(7):701-706. doi: 10.1016/j.healun.2013.04.010
    [19]
    Kim SY, Shin JA, Cho EN, et al. Late respiratory infection after lung transplantation[J]. Tuberc Respir Dis, 2013, 74(2):63-69. doi: 10.4046/trd.2013.74.2.63
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Article Metrics

    Article views (141) PDF downloads(9) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return